Life-threatening chlorpromazine-induced acquired haemophilia A in a patient with a cavernous malformation involving the medulla oblongata

Rev Med Interne. 2022 Dec;43(12):739-742. doi: 10.1016/j.revmed.2022.08.009. Epub 2022 Sep 6.

Abstract

Introduction: Chlorpromazine is a commonly used drug in several medical conditions associated with a wide range of side effects. Few cases of hemostatic disorder have been reported in the literature.

Case report: A 39-year-old man had previously been diagnosed with a cavernous malformation of the medulla oblongata. Chlorpromazine was started to treat persistent hiccups. Twenty days later, the patient presented hepatitis and a pruritic rash. Haemostasis tests revealed a prolonged partial thromboplastin time associated with isolated decrease of factor VIII level and anti-factor VIII antibodies. Magnetic resonance imaging revealed recent asymptomatic bleeding. Introduction of eptacog alfa and prednisone allowed clinical and biological improvement as well as a prolonged remission after 12 months of follow-up.

Keywords: Acquired haemophilia A; Autoimmunity; Chlorpromazine; Haemostasis; Iatrogenic disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chlorpromazine / adverse effects
  • Hemophilia A* / chemically induced
  • Hemophilia A* / diagnosis
  • Hemophilia A* / drug therapy
  • Hemorrhage
  • Humans
  • Male
  • Medulla Oblongata

Substances

  • Chlorpromazine

Supplementary concepts

  • Factor 8 deficiency, acquired